Jingwen Deng
- Hepatology top 10%
- Liver Disease and Transplantation 2
- Pharmacology top 10%
-
- MicroRNA in disease regulation 2
-
- Immune cells in cancer 3
-
- Cancer Immunotherapy and Biomarkers 3
-
- Ferroptosis and cancer prognosis 3
-
- Radiomics and Machine Learning in Medical Imaging 3
-
- Cancer Mechanisms and Therapy 3
-
- AI in cancer detection 3
- Journals
- Advanced Functional Materials (1 paper)Cancer Research (1 paper)ACS Applied Materials & Interfaces (1 paper)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Jingwen Deng
24 papers receiving 501 citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Hepatology 63
- Pharmacology 62
- Cancer Research 95
- Immunology 109
- Oncology 111
Countries citing papers authored by Jingwen Deng
This map shows the geographic impact of Jingwen Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingwen Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingwen Deng more than expected).
Fields of papers citing papers by Jingwen Deng
This network shows the impact of papers produced by Jingwen Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingwen Deng. The network helps show where Jingwen Deng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingwen Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 42 | |
| 10 | 2023 | 15 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 8 | |
| 13 | 2022 | 40 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 15 | |
| 16 | 2021 | 82 | |
| 17 | 2021 | 12 | |
| 18 | 2020 | 4 | |
| 19 | 2019 | 12 | |
| 20 | 2013 | 37 |
About Jingwen Deng
Jingwen Deng is a scholar working on Pharmacology, Cancer Research and Hepatology, having authored 26 papers that have together received 505 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Cancer Mechanisms and Therapy (3 papers), AI in cancer detection (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (3 papers), MicroRNA in disease regulation (2 papers) and Liver Disease and Transplantation (2 papers). The work is most often cited by research in Hepatology (63 citations), Pharmacology (62 citations) and Cancer Research (95 citations). Jingwen Deng has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Zhi Chen, Xiaopeng Cai, Dongxiao Zhang, Zhongfan Liu, Zhen Du, Shiyuan Hua, Min Zhou, Huiqiang Cai, Jun Guan and Yi Zheng. Their work appears in journals such as Advanced Functional Materials, Cancer Research and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.